AstraZeneca Plc is spinning off a company to develop drugs for immune disorders with as much as $250 million from a group of investors.
from Bloomberg http://ift.tt/2t9g2zF
Subscribe to:
Post Comments (Atom)
Tim Tully taught himself to code at age 6 and still codes daily. Here's how computer science took him from startups to AI investing at Menlo Ventures.
Tim Tully is a partner at Menlo Ventures. Menlo Ventures Tim Tully taught himself to code when he was six and went to school for comput...
-
Before investing your own money into a small business idea, test it out with your target audience. Georgijevic/Getty Images Having a bu...
-
Stocks could crash nearly 50% and a recession might hit this year, B. Riley's Paul Dietrich said. Yuichiro Chino/Getty Images The S...
-
The benchmark S&P 500 index just logged its longest losing streak of 2023, per data from Refinitiv. Mario Tama / Getty US stocks...
No comments:
Post a Comment